December 13, 2024 07:00 AM EST

Xaira hires former Roche exec as CMO; 'Tis the season for retirements at Alnylam, Regeneron

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Andrew Dunn

Senior Biopharma Correspondent

The billion-dollar AI-focused startup Xaira Therapeutics deepened its C-suite this week, hiring former Roche executive Paulo Fontoura as its chief medical …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Xaira hires former Roche exec as CMO; 'Tis the season for retirements at Alnylam, Regeneron

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Andrew Dunn

Senior Biopharma Correspondent

Sign up to read this article for free.

Gilead names Dietmar Berger CMO as it eyes R&D reset

Editas to cut 65% of workforce, officially stops work on ex vivo sickle cell therapy

After poor lung cancer data, iTeos drops inupadenant to double down on TIGIT

Inside Isomorphic Labs: Demis Hassabis’ lab-free vision for biotech’s AI future

Safety concerns and trial holds for pediatric RSV vaccines prompt caution from FDA adcomm

The key to faster, more impactful research? Put patients in the driver’s seat

Xaira hires for­mer Roche ex­ec as CMO; 'Tis the sea­son for re­tire­ments at Al­ny­lam, Re­gen­eron

Copy Chief

Editor

Senior Biopharma Correspondent

Sign up to read this article for free.

Xaira hires former Roche exec as CMO; 'Tis the season for retirements at Alnylam, Regeneron